Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences:

Jefferies London Healthcare ConferencePresentation Date and Time: Wednesday, November 19, 2025, at 8:00 a.m. GMTLondon, UK

The presentation will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

Piper Sandler 37th Annual Healthcare ConferenceFireside Chat Date and Time: Tuesday, December 2, 2025, at 2:30 p.m. ETNew York, NY

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

Evercore Healthcare ConferenceThursday, December 4, 2025Coral Gables, FL

About Collegium Pharmaceutical, Inc.Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM®, a differentiated treatment for ADHD. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:Ian KarpHead of Investor Relationsir@collegiumpharma.com 

Danielle JesseDirector, Investor Relationsir@collegiumpharma.com 

Media Contact:Cheryl WheelerHead of Corporate Communicationscommunications@collegiumpharma.com